|
Volumn 27, Issue 5 SUPPL. 10, 2000, Pages 149-152
|
Future treatment options with capecitabine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAPECITABINE;
CYCLOPHOSPHAMIDE;
CYTOTOXIC AGENT;
FLUOROURACIL;
FOLIC ACID;
IRINOTECAN;
MITOMYCIN C;
OXALIPLATIN;
TAXANE DERIVATIVE;
TAXOL;
TAXOTERE;
THYMIDINE PHOSPHORYLASE;
THYMIDYLATE SYNTHASE;
UFT;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER RESISTANCE;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONFERENCE PAPER;
CYTOTOXICITY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENTIATION;
DRUG TARGETING;
DRUG TRANSFORMATION;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DEOXYCYTIDINE;
FORECASTING;
HUMAN;
|
EID: 0033791453
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (3)
|
References (10)
|